Literature DB >> 18678547

Quality of care for lung cancer in Taiwan: a pattern of care based on core measures in the Taiwan Cancer Database registry.

Chun-Ru Chien1, Chun-Ming Tsai, Siew-Tzuh Tang, Kuo-Piao Chung, Chao-Hua Chiu, Mei-Shu Lai.   

Abstract

BACKGROUND/
PURPOSE: To investigate the quality of care (QOC) for lung cancer in Taiwan, as measured by pattern of care (POC) variation.
METHODS: Based on core measures in the Taiwan Cancer Database (TCDB) registry, QOC for lung cancer was measured as variation in POC for 16 selected core measures for different hospital characteristics. Statistical significance in variation was evaluated by the Chi-squared test.
RESULTS: Among the 26 participating hospitals (one excluded as an outlier), 6624 cases of lung cancer were reported in 2004. Among the 16 core measures (6 in the diagnostic and 10 in the therapeutic domain), no significant variation in POC was noted in 12 in northern and non-northern hospitals. However, significant variation in POC was noted for most (5/6) of the core measures in the diagnostic domain for other hospital characteristics (large vs. small, medical center vs. regional hospital, public vs. private). Increasing utilization of tissue diagnosis, diagnostic computed tomography (CT), and CT or magnetic resonance imaging for staging advanced non-small cell lung cancer was noted in the four participating hospitals from 2002 to 2004.
CONCLUSION: It is very likely that significant variation in QOC for lung cancer in Taiwan exists among different types but not locations of hospitals, at least in the diagnostic domain. The introduction of internal benchmarking (TCDB and core measures) was associated with some changes, at least in some diagnostic domains, which may lead to improvement in QOC for lung cancer in Taiwan.

Entities:  

Mesh:

Year:  2008        PMID: 18678547     DOI: 10.1016/S0929-6646(08)60181-3

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  6 in total

1.  The Victorian Lung Cancer Registry pilot: improving the quality of lung cancer care through the use of a disease quality registry.

Authors:  Rob G Stirling; S M Evans; P McLaughlin; M Senthuren; J Millar; J Gooi; L Irving; P Mitchell; A Haydon; J Ruben; M Conron; T Leong; N Watkins; J J McNeil
Journal:  Lung       Date:  2014-06-08       Impact factor: 2.584

2.  Combretastatin A-4 derivatives: synthesis and evaluation of 2,4,5-triaryl-1H-imidazoles as potential agents against H1299 (non-small cell lung cancer cell).

Authors:  Chih-Hua Tseng; Chi-Yi Li; Chien-Chih Chiu; Huei-Ting Hu; Chein-Hwa Han; Yeh-Long Chen; Cherng-Chyi Tzeng
Journal:  Mol Divers       Date:  2012-09-26       Impact factor: 2.943

3.  Is quality of colorectal cancer care good enough? Core measures development and its application for comparing hospitals in Taiwan.

Authors:  Kuo-Piao Chung; Yun-Jau Chang; Mei-Shu Lai; Raymond Nien-Chen Kuo; Skye H Cheng; Li-Tzong Chen; Reiping Tang; Tsang-Wu Liu; Ming-Jium Shieh
Journal:  BMC Health Serv Res       Date:  2010-01-27       Impact factor: 2.655

4.  Cytotoxic Chemotherapy as First-Line Therapy for Advanced Non-Small-Cell Lung Cancer in Taiwan: Daily Practice.

Authors:  Yi-Hsin Liang; Yu-Yun Shao; Bin-Chi Liao; Ho-Sheng Lee; James Chih-Hsin Yang; Ho-Min Chen; Chun-Ju Chiang; Ann-Lii Cheng; Mei-Shu Lai
Journal:  J Cancer       Date:  2016-07-07       Impact factor: 4.207

5.  Health care resource use among patients with advanced non-small cell lung cancer: the PIvOTAL retrospective observational study.

Authors:  Dae Ho Lee; Hiroshi Isobe; Hubert Wirtz; Sabina Bandeira Aleixo; Phillip Parente; Filippo de Marinis; Min Huang; Ashwini Arunachalam; Smita Kothari; Xiting Cao; Nello Donnini; Ann-Marie Woodgate; Javier de Castro
Journal:  BMC Health Serv Res       Date:  2018-03-01       Impact factor: 2.655

6.  Development of quality indicators for non-small cell lung cancer care: a first step toward assessing and improving quality of cancer care in China.

Authors:  Xinyu Wang; Shaofei Su; Shouyi Li; Han Bao; Meiqi Zhang; Dan Liu; Hao Jiang; Jiaying Wang; Meina Liu
Journal:  BMC Cancer       Date:  2017-08-31       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.